1. Home
  2. IMCC vs APVO Comparison

IMCC vs APVO Comparison

Compare IMCC & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • APVO
  • Stock Information
  • Founded
  • IMCC 1980
  • APVO 2016
  • Country
  • IMCC Israel
  • APVO United States
  • Employees
  • IMCC N/A
  • APVO N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMCC Health Care
  • APVO Health Care
  • Exchange
  • IMCC Nasdaq
  • APVO Nasdaq
  • Market Cap
  • IMCC 7.5M
  • APVO 6.5M
  • IPO Year
  • IMCC N/A
  • APVO N/A
  • Fundamental
  • Price
  • IMCC $2.37
  • APVO $3.95
  • Analyst Decision
  • IMCC
  • APVO Strong Buy
  • Analyst Count
  • IMCC 0
  • APVO 1
  • Target Price
  • IMCC N/A
  • APVO $296.00
  • AVG Volume (30 Days)
  • IMCC 16.9K
  • APVO 46.8K
  • Earning Date
  • IMCC 03-27-2025
  • APVO 03-04-2025
  • Dividend Yield
  • IMCC N/A
  • APVO N/A
  • EPS Growth
  • IMCC N/A
  • APVO N/A
  • EPS
  • IMCC N/A
  • APVO N/A
  • Revenue
  • IMCC $38,042,859.00
  • APVO N/A
  • Revenue This Year
  • IMCC $22.59
  • APVO N/A
  • Revenue Next Year
  • IMCC $32.86
  • APVO N/A
  • P/E Ratio
  • IMCC N/A
  • APVO N/A
  • Revenue Growth
  • IMCC N/A
  • APVO N/A
  • 52 Week Low
  • IMCC $1.41
  • APVO $3.65
  • 52 Week High
  • IMCC $8.10
  • APVO $399.60
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 53.35
  • APVO 39.61
  • Support Level
  • IMCC $2.05
  • APVO $3.77
  • Resistance Level
  • IMCC $2.60
  • APVO $4.47
  • Average True Range (ATR)
  • IMCC 0.21
  • APVO 0.29
  • MACD
  • IMCC 0.02
  • APVO 0.08
  • Stochastic Oscillator
  • IMCC 58.31
  • APVO 38.40

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: